Medbox Inc. Featured in Wall Street Journal

                 Medbox Inc. Featured in Wall Street Journal

Article Suggested that Medbox may be an Excellent Investment

PR Newswire

HOLLYWOOD, Calif., Nov. 15, 2012

HOLLYWOOD, Calif., Nov. 15, 2012 /PRNewswire/ -- Medbox, Inc. (Ticker: MDBX)
(, was featured in an article in the MarketWatch section of
the Wall Street Journal, which suggested that investing in certain companies
right now is similar to getting in on the gold rush at just the right

According to the article, investing in companies that supply services to the
legalized medical marijuana industry is being called "The Green Rush," and can
provide investors with the means to profit from the fast-growing medical
marijuana industry - estimated to be worth about $1.7 billion as of 2011 –
without investing in the sale of the drug itself. The article quoted Medbox
company founder, Vincent Mehdizadeh, as stating, "The smart money is trying to
help with compliance and transparency."

"For regular investors looking to get in on the action — and without having to
actually grow or sell drugs — there are several small-cap stocks that stand to
gain from marijuana's growing acceptance," the article stated. "Medbox
(US:MDBX), an OTC stock with a $45 million market cap, for example, sells its
patented dispensing machines to licensed medical-marijuana dispensaries. The
machines, which dispense set doses of the drug after verifying patients'
identities via fingerprint, could potentially be used in ordinary drugstores,

Medbox, which has seen its stock price skyrocket in the past few days, is a
leader in providing the industry with tools for increased transparency and
compliance – key components to the sector's growth.

"While we are encouraged and extremely excited by the dramatic increase in our
stock price, we also believe that supply is simply not meeting demand for our
stock, which is in turn boosting the price to never before seen levels,"
stated Bruce Bedrick, CEO of Medbox, Inc. "Our strong financials, focus on
several market niches – including traditional prescription medicine
dispensing, and a favorable political environment have all contributed to the
strong demand for our company's stock. In the coming months, we will be
expanding our shareholder base directly from the company, so that the market
demand can be satisfied," he added.

To read the article in the Wall Street Journal, please visit:

For more information, contact Medbox Investor Relations at: (800) 762-1452.

About Medbox, Inc:
Medbox is a leader in the development, sales and service of automated,
biometrically controlled dispensing and storage systems for medicine and
merchandise. Medbox has offices throughout the world, including New York,
Arizona, Connecticut, Massachusetts, Tokyo, London and Toronto, and has their
corporate headquarters in Los Angeles.

Medbox provides their patented systems, software and consulting services to
pharmacies, urgent care centers, clinics, hospitals, and medical groups

Medbox, Inc. is a publicly traded company, and is listed on the OTC Board,
ticker symbol MDBX.

For more information on Medbox, please contact the Medbox Investor Relations
Department at (800) 762-1452 or go online to

SOURCE Medbox, Inc.

Contact: RAH Marketing,
Press spacebar to pause and continue. Press esc to stop.